StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.29−0.44 (-6.54%)

Close on Nov 16, 2026Market cap $283.18MP/E –Yield –

Agenus operating margin

Operating margin is operating income as a percentage of revenue.

Agenus's operating margin for the twelve months ending Jun 30, 2026 was 27.3%. For fiscal 2025 it was -17.7%, against -116.4% the year before. The highest annual figure on record is 8.7% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-17.7%+98.8
FY2024Dec 31, 2024-116.4%−14.4
FY2023Dec 31, 2023-102.1%+81.0
FY2022Dec 31, 2022-183.0%−191.8
FY2021Dec 31, 20218.7%+141.7
FY2020Dec 31, 2020-133.0%−86.2
FY2019Dec 31, 2019-46.7%+289.9
FY2018Dec 31, 2018-336.6%−94.5
FY2017Dec 31, 2017-242.1%+234.0
FY2016Dec 31, 2016-476.1%−150.9
FY2015Dec 31, 2015-325.2%+295.7
FY2014Dec 31, 2014-620.9%+199.4
FY2013Dec 31, 2013-820.3%−778.1
FY2012Dec 31, 2012-42.2%+650.4
FY2011Dec 31, 2011-692.6%−45.1
FY2010Dec 31, 2010-647.5%+182.6
FY2009Dec 31, 2009-830.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202632.7%+97.8
Q1 FY2026Mar 31, 202644.6%+99.9
Q4 FY2025Dec 31, 202542.1%+138.6
Q3 FY2025Sep 30, 2025-15.0%+110.4
Q2 FY2025Jun 30, 2025-65.0%+63.4
Q1 FY2025Mar 31, 2025-55.3%+62.1
Q4 FY2024Dec 31, 2024-96.5%−91.5
Q3 FY2024Sep 30, 2024-125.5%+65.1
Q2 FY2024Jun 30, 2024-128.4%+87.7
Q1 FY2024Mar 31, 2024-117.4%+119.9
Q4 FY2023Dec 31, 2023-5.0%+198.5
Q3 FY2023Sep 30, 2023-190.6%−7.7
Q2 FY2023Jun 30, 2023-216.1%−3.1
Q1 FY2023Mar 31, 2023-237.3%−100.6
Q4 FY2022Dec 31, 2022-203.5%+63.2
Q3 FY2022Sep 30, 2022-182.9%−257.0
Q2 FY2022Jun 30, 2022-213.0%+405.8
Q1 FY2022Mar 31, 2022-136.7%+216.3
Q4 FY2021Dec 31, 2021-266.7%−197.2
Q3 FY2021Sep 30, 202174.1%+308.7
Q2 FY2021Jun 30, 2021-618.8%−495.3
Q1 FY2021Mar 31, 2021-353.0%−171.5
Q4 FY2020Dec 31, 2020-69.4%−13.6
Q3 FY2020Sep 30, 2020-234.6%−54.4
Q2 FY2020Jun 30, 2020-123.5%+138.3
Q1 FY2020Mar 31, 2020-181.5%−214.3
Q4 FY2019Dec 31, 2019-55.9%+555.3
Q3 FY2019Sep 30, 2019-180.2%+23.5
Q2 FY2019Jun 30, 2019-261.8%−157.6
Q1 FY2019Mar 31, 201932.8%+2584.7
Q4 FY2018Dec 31, 2018-611.1%−252.1
Q3 FY2018Sep 30, 2018-203.7%+739.0
Q2 FY2018Jun 30, 2018-104.3%+582.2
Q1 FY2018Mar 31, 2018-2551.9%−2502.7
Q4 FY2017Dec 31, 2017-359.0%−6.1
Q3 FY2017Sep 30, 2017-942.7%−127.9
Q2 FY2017Jun 30, 2017-686.5%–
Q1 FY2017Mar 31, 2017-49.2%–
Q4 FY2016Dec 31, 2016-352.9%–
Q3 FY2016Sep 30, 2016-814.8%–

More Agenus figures

See a number that looks wrong?